Medical research in acute treatment improves survivability and mitigates long-term disability for Service Members with injuries following blast events. The Department of Defense (DoD) collaborates with the US Food and Drug Administration (FDA), academia, and the private sector to investigate new diagnostic tools, therapies for traumatic brain injury (TBI), hemorrhage control devices, strategies to mitigate wound infection, and medical interventions for facial, hearing, and visual injuries. The research community is also employing novel neuroimaging techniques, evaluating clinical data, and experimenting in the laboratory to improve treatment and injury mitigation across the spectrum of blast-related injuries. The combined efforts of this research are leading to a greater understanding of the capabilities and limitations of current technologies, new and improved tools, and validated methods for injury mitigation in the prehospital setting, and improved diagnostics and clinical guidelines for the acute treatment of blast injuries.
Your 15 minute session will timeout in approximately 10 minutes.
If you're in the middle of entering information, please close this warning and save your progress (if possible) or finish up your task.
If your session fully times out, you will lose any un-saved work.
Your current Blast Injury Research Program session has expired.
Your next click will take you away from the private area, and you will lose any work you have in-progress.
Please enter your email address, and try again.